|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Hydrogen Peroxide]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Malondialdehyde]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:15607907 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
isorhapontigenin results in decreased expression of CCND1 protein |
CTD |
PMID:37619952 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in increased expression of CDH1 protein |
CTD |
PMID:37619952 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased localization of CTNNB1 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased phosphorylation of CTNNB1 protein |
CTD |
PMID:37619952 |
|
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT1 protein |
CTD |
PMID:37619952 |
|
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
|
|
G |
Dnmt3a |
DNA methyltransferase 3A |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3A protein |
CTD |
PMID:37619952 |
|
NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443
|
|
G |
Dnmt3b |
DNA methyltransferase 3B |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3B protein |
CTD |
PMID:37619952 |
|
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
affects expression |
ISO |
isorhapontigenin affects the expression of FOS protein |
CTD |
PMID:15607907 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in increased phosphorylation of GSK3B protein |
CTD |
PMID:37619952 |
|
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Ikbkb |
inhibitor of kappaB kinase beta |
affects activity |
ISO |
isorhapontigenin affects the activity of IKBKB protein |
CTD |
PMID:15607907 |
|
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
|
|
G |
Jun |
jun proto-oncogene |
affects expression |
ISO |
isorhapontigenin affects the expression of JUN protein |
CTD |
PMID:15607907 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15607907 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15607907 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:15607907 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Meg3 |
maternally expressed 3 |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [sodium bichromate results in decreased expression of MEG3] |
CTD |
PMID:37619952 |
|
NCBI chr12:109,506,879...109,538,163
Ensembl chr12:109,506,877...109,538,165
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
decreases expression |
ISO |
isorhapontigenin results in decreased expression of MKI67 protein |
CTD |
PMID:37619952 |
|
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated gene 9 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of and results in decreased localization of NEDD9 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of NEDD9 mRNA |
CTD |
PMID:37619952 |
|
NCBI chr13:41,463,392...41,640,836
Ensembl chr13:41,463,057...41,640,838
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
ISO |
isorhapontigenin affects the degradation of and affects the phosphorylation of NFKBIA protein |
CTD |
PMID:15607907 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Snai2 |
snail family zinc finger 2 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of SNAI2 protein |
CTD |
PMID:37619952 |
|
NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [potassium oxonate results in increased expression of ABCG2 protein] |
CTD |
PMID:22865646 |
|
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
increases expression |
ISO |
pterostilbene results in increased expression of ACADM mRNA |
CTD |
PMID:26443543 |
|
NCBI chr 3:153,627,990...153,650,280
Ensembl chr 3:153,627,994...153,650,269
|
|
G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
multiple interactions |
ISO |
[Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of ACOX1 protein |
CTD |
PMID:25083823 |
|
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
increases activity multiple interactions |
ISO |
pterostilbene results in increased activity of AHR protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [pterostilbene results in increased activity of AHR protein]; pterostilbene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:28279696 PMID:31004704 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Azoxymethane results in increased expression of AKR1B1 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of AKR1B1 protein] |
CTD |
PMID:21355597 |
|
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
decreases expression increases phosphorylation multiple interactions |
ISO |
pterostilbene results in decreased expression of AKT1 mRNA pterostilbene results in increased phosphorylation of AKT1 protein pterostilbene results in decreased phosphorylation of and results in decreased activity of AKT1 protein |
CTD |
PMID:20152895 PMID:24154491 PMID:31139082 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
decreases expression |
ISO |
pterostilbene results in decreased expression of AMACR mRNA |
CTD |
PMID:20152895 |
|
NCBI chr15:10,981,875...10,995,693
Ensembl chr15:10,981,842...10,996,712
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form] |
CTD |
PMID:19549798 |
|
NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
EXP ISO |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] |
CTD |
PMID:34405320 |
|
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
|
|
G |
Atg7 |
autophagy related 7 |
multiple interactions |
ISO |
ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression multiple interactions |
EXP ISO |
pterostilbene results in increased expression of BAD protein pterostilbene inhibits the reaction [sodium arsenite results in increased expression of BAD protein] |
CTD |
PMID:20681671 PMID:31139082 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
pterostilbene results in increased expression of BAK1 protein |
CTD |
PMID:23313376 |
|
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
|
|
G |
Bax |
BCL2-associated X protein |
affects response to substance increases expression multiple interactions |
ISO EXP |
BAX protein affects the susceptibility to pterostilbene pterostilbene results in increased expression of BAX protein pterostilbene results in increased expression of BAX mRNA; pterostilbene results in increased expression of BAX protein pterostilbene inhibits the reaction [sodium arsenite results in increased expression of BAX protein] |
CTD |
PMID:20152895 PMID:20681671 PMID:22572619 PMID:23313376 PMID:24936659 PMID:31139082 More...
|
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions increases expression decreases expression |
ISO EXP |
[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein; pterostilbene inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]; RELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein] pterostilbene results in increased expression of BCL2 protein pterostilbene results in decreased expression of BCL2 mRNA; pterostilbene results in decreased expression of BCL2 protein |
CTD |
PMID:18852136 PMID:20152895 PMID:20681671 PMID:24936659 PMID:31139082 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
increases expression multiple interactions decreases expression |
EXP ISO |
pterostilbene results in increased expression of BCL2L1 protein pterostilbene inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein] pterostilbene results in decreased expression of BCL2L1 protein |
CTD |
PMID:20681671 PMID:23313376 PMID:31139082 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Becn1 |
beclin 1, autophagy related |
multiple interactions |
ISO EXP |
BECN1 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]] |
CTD |
PMID:34405320 |
|
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression |
EXP |
pterostilbene results in increased expression of BID protein modified form |
CTD |
PMID:20681671 |
|
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
|
|
G |
Camp |
cathelicidin antimicrobial peptide |
multiple interactions increases expression |
ISO |
calcipotriene promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [pterostilbene results in increased expression of CAMP protein]; paricalcitol promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; pterostilbene promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]; pterostilbene promotes the reaction [Calcitriol results in increased expression of CAMP protein] pterostilbene results in increased expression of CAMP mRNA; pterostilbene results in increased expression of CAMP protein |
CTD |
PMID:24039193 |
|
NCBI chr 9:109,676,445...109,678,524
Ensembl chr 9:109,676,447...109,678,685
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions increases activity increases expression |
EXP ISO |
pterostilbene results in increased cleavage of CASP3 protein 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP3 protein]; pterostilbene inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP3 protein] pterostilbene results in increased expression of CASP3 mRNA |
CTD |
PMID:20152895 PMID:20681671 PMID:23313376 PMID:24936659 PMID:25341683 PMID:31139082 PMID:33930484 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
multiple interactions increases activity |
ISO |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased activity of CASP4 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP4 protein] |
CTD |
PMID:25341683 |
|
NCBI chr 9:5,308,816...5,336,791
Ensembl chr 9:5,308,828...5,336,783
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP7 protein] |
CTD |
PMID:33930484 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
EXP |
pterostilbene results in increased cleavage of and results in increased activity of CASP8 protein |
CTD |
PMID:20681671 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases expression multiple interactions increases activity increases cleavage |
ISO EXP |
pterostilbene results in increased expression of CASP9 protein pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP9 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP9 protein] pterostilbene results in increased cleavage of CASP9 protein |
CTD |
PMID:20152895 PMID:20681671 PMID:25341683 PMID:33930484 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions increases expression |
ISO EXP |
CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]] pterostilbene inhibits the reaction [Streptozocin results in decreased expression of CAT] pterostilbene results in increased expression of CAT mRNA |
CTD |
PMID:25341683 PMID:26700463 PMID:34474091 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccn1 |
cellular communication network factor 1 |
multiple interactions |
EXP ISO |
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein] 3-methyladenine inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; Ammonium Chloride inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; BECN1 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; Chloroquine inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein] |
CTD |
PMID:34405320 |
|
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO EXP |
pterostilbene results in decreased expression of CCND1 protein pterostilbene inhibits the reaction [Azoxymethane results in increased expression of CCND1 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of CCND1 protein] |
CTD |
PMID:19549798 PMID:20398797 PMID:20681671 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
pterostilbene results in decreased expression of CCNE1 protein |
CTD |
PMID:20398797 |
|
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions increases expression |
EXP ISO |
pterostilbene inhibits the reaction [Azoxymethane results in decreased expression of CDH1 protein] pterostilbene results in increased expression of CDH1 protein |
CTD |
PMID:20681671 PMID:23921149 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
pterostilbene results in decreased expression of CDK2 protein |
CTD |
PMID:20398797 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdk4 |
cyclin dependent kinase 4 |
decreases expression |
ISO |
pterostilbene results in decreased expression of CDK4 protein |
CTD |
PMID:20398797 |
|
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO EXP |
pterostilbene results in increased expression of CDKN1A protein CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN1A protein]] |
CTD |
PMID:23313376 PMID:34405320 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
increases expression |
ISO |
pterostilbene results in increased expression of CDKN1B protein |
CTD |
PMID:23313376 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
multiple interactions |
ISO EXP |
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN2A protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
multiple interactions |
ISO |
[Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of CPT1A protein |
CTD |
PMID:25083823 |
|
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
multiple interactions |
ISO |
[resveratrol co-treated with pterostilbene co-treated with Quercetin co-treated with tocotrienol, delta co-treated with Niacin] results in decreased expression of CRP protein |
CTD |
PMID:24319627 |
|
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization increases expression |
ISO |
pterostilbene affects the localization of CYCS protein pterostilbene results in increased expression of CYCS mRNA; pterostilbene results in increased expression of CYCS protein |
CTD |
PMID:22450950 PMID:22572619 PMID:26443543 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression increases expression multiple interactions |
ISO |
pterostilbene results in decreased expression of CYP1A1 mRNA pterostilbene results in increased expression of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [pterostilbene results in increased expression of CYP1A1 protein] |
CTD |
PMID:22450950 PMID:31004704 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
EXP ISO |
pterostilbene results in decreased activity of CYP1A2 protein |
CTD |
PMID:16684708 PMID:30394306 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
increases expression |
ISO |
pterostilbene results in increased expression of CYP2B6 mRNA |
CTD |
PMID:30394306 |
|
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
|
|
G |
Cyp2c38 |
cytochrome P450, family 2, subfamily c, polypeptide 38 |
decreases activity |
ISO |
pterostilbene results in decreased activity of CYP2C19 protein |
CTD |
PMID:30394306 |
|
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of DDIT3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased expression of DDIT3 protein] pterostilbene results in increased expression of DDIT3 mRNA; pterostilbene results in increased expression of DDIT3 protein |
CTD |
PMID:22450950 PMID:25341683 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Dffa |
DNA fragmentation factor, alpha subunit |
increases cleavage |
EXP |
pterostilbene results in increased cleavage of DFFA protein |
CTD |
PMID:20681671 |
|
NCBI chr 4:149,188,599...149,205,110
Ensembl chr 4:149,188,603...149,205,104
|
|
G |
Dhrs2 |
dehydrogenase/reductase member 2 |
increases expression |
ISO |
pterostilbene results in increased expression of DHRS2 mRNA; pterostilbene results in increased expression of DHRS2 protein |
CTD |
PMID:24936659 |
|
NCBI chr14:55,459,464...55,478,897
Ensembl chr14:55,459,464...55,478,892
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
increases expression affects localization |
ISO |
pterostilbene results in increased expression of DIABLO protein pterostilbene affects the localization of DIABLO protein |
CTD |
PMID:22450950 PMID:22572619 |
|
NCBI chr 5:123,649,393...123,664,825
Ensembl chr 5:123,647,828...123,662,239
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
ISO |
[resveratrol co-treated with pterostilbene] results in decreased expression of DNMT1 mRNA |
CTD |
PMID:26459286 |
|
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
|
|
G |
Dnmt3a |
DNA methyltransferase 3A |
multiple interactions |
ISO |
[resveratrol co-treated with pterostilbene] results in decreased expression of DNMT3A mRNA |
CTD |
PMID:26459286 |
|
NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443
|
|
G |
Dnmt3b |
DNA methyltransferase 3B |
multiple interactions |
ISO |
pterostilbene promotes the reaction [resveratrol results in decreased expression of DNMT3B mRNA] |
CTD |
PMID:26459286 |
|
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGF protein] |
CTD |
PMID:19447859 |
|
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGFR protein] |
CTD |
PMID:19447859 |
|
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
ISO |
pterostilbene results in increased phosphorylation of EIF2A protein |
CTD |
PMID:25341683 |
|
NCBI chr 3:58,433,252...58,464,922
Ensembl chr 3:58,433,242...58,464,922
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions increases phosphorylation |
ISO |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:25341683 |
|
NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
|
|
G |
Elk1 |
ELK1, member of ETS oncogene family |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form] |
CTD |
PMID:19549798 |
|
NCBI chr X:20,799,634...20,816,847
Ensembl chr X:20,799,634...20,816,847
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
increases expression multiple interactions |
ISO |
pterostilbene results in increased expression of ESR1 protein [resveratrol co-treated with pterostilbene] results in increased expression of ESR1 mRNA; [resveratrol co-treated with pterostilbene] results in increased expression of ESR1 protein |
CTD |
PMID:27159275 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Esr2 |
estrogen receptor 2 (beta) |
multiple interactions |
EXP |
ESR2 gene mutant form inhibits the reaction [pterostilbene results in increased expression of SOD2 protein] |
CTD |
PMID:24361291 |
|
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
pterostilbene results in increased expression of FAS protein |
CTD |
PMID:20681671 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fasl |
Fas ligand |
increases expression |
EXP |
pterostilbene results in increased expression of FASL protein |
CTD |
PMID:20681671 |
|
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
ISO |
[Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of FASN protein |
CTD |
PMID:25083823 |
|
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of FOS protein] |
CTD |
PMID:18551458 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Fut1 |
fucosyltransferase 1 |
increases expression |
ISO |
pterostilbene results in increased expression of FUT1 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr 7:45,266,862...45,270,483
Ensembl chr 7:45,266,713...45,270,483
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
pterostilbene results in increased expression of GDF15 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
|
|
G |
Glo1 |
glyoxalase 1 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of GLO1 protein] |
CTD |
PMID:33930484 |
|
NCBI chr17:30,811,835...30,831,633
Ensembl chr17:30,803,910...30,845,845
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of GPX1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA] |
CTD |
PMID:25341683 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:20681671 |
|
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Gsr |
glutathione reductase |
multiple interactions decreases expression |
EXP ISO |
NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA] pterostilbene results in decreased expression of GSR mRNA |
CTD |
PMID:21355597 PMID:25341683 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO EXP |
[Resveratrol co-treated with pterostilbene] results in decreased expression of H2AX protein modified form; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of H2AX protein modified form]] |
CTD |
PMID:26459286 PMID:34405320 |
|
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions increases phosphorylation |
ISO |
HDAC5 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of HDAC5 protein]; pterostilbene inhibits the reaction [HDAC5 protein binds to SOD2 promoter] |
CTD |
PMID:26443543 |
|
NCBI chr11:102,085,244...102,120,968
Ensembl chr11:102,085,258...102,120,992
|
|
G |
Hmga1 |
high mobility group AT-hook 1 |
multiple interactions |
ISO EXP |
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased secretion of HMGA1 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]] CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]] |
CTD |
PMID:34405320 PMID:34474091 |
|
NCBI chr17:27,774,798...27,782,649
Ensembl chr17:27,775,471...27,782,648
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of HMGB1 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
pterostilbene results in increased expression of HMOX1 mRNA; pterostilbene results in increased expression of HMOX1 protein [pterostilbene co-treated with kaempferol] results in increased expression of HMOX1 mRNA; pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of HMOX1 mRNA]; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of HMOX1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]] NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 protein] |
CTD |
PMID:21355597 PMID:22450950 PMID:25111660 PMID:31139082 PMID:33930484 PMID:34474091 More...
|
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
increases expression |
ISO |
pterostilbene results in increased expression of HNRNPM mRNA |
CTD |
PMID:22450950 |
|
NCBI chr17:33,865,207...33,904,432
Ensembl chr17:33,865,207...33,905,834
|
|
G |
Hspa5 |
heat shock protein 5 |
multiple interactions increases expression |
ISO |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of HSPA5 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased expression of HSPA5 protein] pterostilbene results in increased expression of HSPA5 mRNA; pterostilbene results in increased expression of HSPA5 protein |
CTD |
PMID:25341683 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspa9 |
heat shock protein 9 |
increases expression |
ISO |
pterostilbene results in increased expression of HSPA9 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
|
|
G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
decreases expression |
ISO |
pterostilbene results in decreased expression of HSPE1 protein |
CTD |
PMID:24936659 |
|
NCBI chr 1:55,127,307...55,130,476
Ensembl chr 1:55,127,291...55,130,466
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO EXP |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IFNG protein] pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]] |
CTD |
PMID:19549798 PMID:22698256 PMID:34405320 PMID:34474091 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO EXP |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased secretion of IL1A protein] CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA] |
CTD |
PMID:34405320 PMID:34474091 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]] pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:19549798 PMID:22698256 PMID:34474091 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP ISO |
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL6 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]] |
CTD |
PMID:22698256 PMID:34405320 PMID:34474091 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Ins1 |
insulin I |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Streptozocin results in decreased secretion of INS1 protein] |
CTD |
PMID:26700463 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Itgb8 |
integrin beta 8 |
decreases expression increases expression |
ISO |
pterostilbene results in decreased expression of ITGB8 mRNA pterostilbene results in increased expression of ITGB8 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr12:119,121,757...119,202,891
Ensembl chr12:119,121,757...119,202,537
|
|
G |
Jak2 |
Janus kinase 2 |
decreases phosphorylation |
ISO |
pterostilbene results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:23313376 |
|
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of JUN protein] |
CTD |
PMID:18551458 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Keap1 |
kelch-like ECH-associated protein 1 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] |
CTD |
PMID:26700463 |
|
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
|
|
G |
Klf2 |
Kruppel-like transcription factor 2 (lung) |
multiple interactions increases expression |
ISO |
MAPK7 protein affects the reaction [pterostilbene results in increased expression of KLF2 mRNA]; pterostilbene promotes the reaction [KLF2 protein binds to SOD2 promoter] pterostilbene results in increased expression of KLF2 mRNA; pterostilbene results in increased expression of KLF2 protein |
CTD |
PMID:26443543 |
|
NCBI chr 8:73,072,906...73,075,498
Ensembl chr 8:73,072,877...73,075,500
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of LAMP1 protein] |
CTD |
PMID:34405320 |
|
NCBI chr 8:13,209,161...13,225,338
Ensembl chr 8:13,209,161...13,225,338
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
ISO |
pterostilbene results in decreased expression of LDLR mRNA |
CTD |
PMID:22153697 |
|
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
EXP ISO |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pterostilbene results in increased phosphorylation of MAPK1 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]; pterostilbene results in increased phosphorylation of and results in increased activity of MAPK1 protein pterostilbene results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:19447859 PMID:24154491 PMID:26138072 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
multiple interactions |
ISO |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]] |
CTD |
PMID:19549798 |
|
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pterostilbene results in increased phosphorylation of MAPK3 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]; pterostilbene results in increased phosphorylation of and results in increased activity of MAPK3 protein pterostilbene results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:19447859 PMID:24154491 PMID:26138072 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk7 |
mitogen-activated protein kinase 7 |
multiple interactions increases phosphorylation |
ISO |
MAPK7 protein affects the reaction [pterostilbene results in increased expression of KLF2 mRNA]; MAPK7 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of MAPK7 protein] |
CTD |
PMID:26443543 |
|
NCBI chr11:61,379,638...61,385,101
Ensembl chr11:61,379,638...61,385,232
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK8 protein]; pterostilbene results in decreased phosphorylation of and results in decreased activity of MAPK8 protein |
CTD |
PMID:19447859 PMID:24154491 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein]; pterostilbene results in decreased phosphorylation of and results in decreased activity of MAPK9 protein |
CTD |
PMID:19447859 PMID:24154491 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mcl1 |
myeloid cell leukemia sequence 1 |
decreases expression |
ISO |
pterostilbene results in decreased expression of MCL1 protein |
CTD |
PMID:23313376 |
|
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
|
|
G |
Mlkl |
mixed lineage kinase domain-like |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Ethanol results in increased phosphorylation of MLKL protein] |
CTD |
PMID:34474091 |
|
NCBI chr 8:112,037,879...112,065,081
Ensembl chr 8:112,038,429...112,064,809
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP2 protein] |
CTD |
PMID:20681671 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp28 |
matrix metallopeptidase 28 (epilysin) |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Azoxymethane results in increased activity of MMP26 protein] |
CTD |
PMID:20681671 |
|
NCBI chr11:83,331,594...83,353,890
Ensembl chr11:83,331,594...83,353,897
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Azoxymethane results in increased activity of MMP7 protein]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of MMP7 mRNA]; pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP2 protein]; pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein] |
CTD |
PMID:20681671 |
|
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,587
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression decreases activity multiple interactions |
ISO EXP |
pterostilbene results in decreased expression of MMP9 mRNA pterostilbene results in decreased activity of MMP9 protein pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein] pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] |
CTD |
PMID:19447859 PMID:19617202 PMID:20152895 PMID:20681671 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Myc |
myelocytomatosis oncogene |
decreases expression |
ISO |
pterostilbene results in decreased expression of MYC protein |
CTD |
PMID:19549798 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
multiple interactions |
ISO |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of HMGB1 protein]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NFATC4 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr14:56,062,252...56,071,400
Ensembl chr14:56,060,601...56,071,400
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions affects localization increases expression increases phosphorylation |
EXP ISO |
NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]]; NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]]; pterostilbene inhibits the reaction [NFE2L2 protein binds to KEAP1 protein]; pterostilbene inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein]; pterostilbene inhibits the reaction [Streptozocin results in decreased phosphorylation of and affects the localization of NFE2L2 protein]; pterostilbene results in increased expression of and results in increased localization of NFE2L2 protein; pterostilbene results in increased phosphorylation of and affects the localization of NFE2L2 protein pterostilbene affects the localization of NFE2L2 protein pterostilbene results in increased expression of NFE2L2 protein pterostilbene results in increased phosphorylation of NFE2L2 protein 2-tert-butylhydroquinone promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde affects the localization of NFE2L2 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]] |
CTD |
PMID:21355597 PMID:25341683 PMID:26700463 PMID:31139082 PMID:33930484 PMID:34474091 More...
|
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
multiple interactions |
ISO |
[pterostilbene co-treated with Quercetin] results in decreased activity of [NFKB1 protein binds to RELA protein] |
CTD |
PMID:18852136 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
ISO EXP |
[pterostilbene co-treated with Quercetin] results in decreased degradation of NFKBIA protein; [pterostilbene co-treated with Quercetin] results in decreased phosphorylation of NFKBIA protein pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NFKBIA protein] |
CTD |
PMID:18551458 PMID:18852136 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
ISO EXP |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein] pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NOS2 protein] |
CTD |
PMID:18551458 PMID:19549798 PMID:20681671 PMID:21355597 PMID:22698256 PMID:22842666 PMID:23731018 More...
|
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
increases expression multiple interactions |
ISO |
pterostilbene results in increased expression of NQO1 mRNA; pterostilbene results in increased expression of NQO1 protein [pterostilbene co-treated with kaempferol] results in increased expression of NQO1 protein; [pterostilbene co-treated with Quercetin] results in increased expression of NQO1 protein; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of NQO1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]] |
CTD |
PMID:25111660 PMID:25341683 PMID:31139082 PMID:34474091 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nqo2 |
N-ribosyldihydronicotinamide quinone reductase 2 |
increases expression |
ISO |
pterostilbene results in increased expression of NQO2 mRNA; pterostilbene results in increased expression of NQO2 protein |
CTD |
PMID:24936659 |
|
NCBI chr13:34,148,642...34,172,448
Ensembl chr13:34,148,670...34,172,426
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions affects binding |
ISO |
pterostilbene binds to and results in increased activity of NR1I2 protein pterostilbene binds to NR1I2 protein |
CTD |
PMID:20869355 PMID:30394306 |
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
pterostilbene binds to and results in increased activity of NR1I3 protein alternative form |
CTD |
PMID:20869355 |
|
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases expression multiple interactions |
ISO |
pterostilbene results in increased expression of PARP1 protein modified form pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of PARP1 protein] |
CTD |
PMID:19549798 PMID:33930484 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
pterostilbene results in decreased expression of PCNA protein |
CTD |
PMID:20398797 |
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
increases expression |
ISO |
pterostilbene results in increased expression of PDK4 mRNA |
CTD |
PMID:26443543 |
|
NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
decreases expression |
ISO |
pterostilbene results in decreased expression of PGAM1 protein |
CTD |
PMID:24936659 |
|
NCBI chr19:41,900,310...41,907,104
Ensembl chr19:41,900,362...41,907,099
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
[resveratrol co-treated with pterostilbene] promotes the reaction [afimoxifene results in decreased expression of PGR mRNA]; [resveratrol co-treated with pterostilbene] promotes the reaction [Estradiol results in increased expression of PGR mRNA] |
CTD |
PMID:27159275 |
|
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
pterostilbene binds to and results in increased activity of PPARA protein pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]] |
CTD |
PMID:15853379 PMID:34474091 |
|
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
increases expression |
ISO |
pterostilbene results in increased expression of PPARGC1A mRNA |
CTD |
PMID:26443543 |
|
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
multiple interactions increases phosphorylation |
ISO |
PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of HDAC5 protein]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of MAPK7 protein] pterostilbene results in increased phosphorylation of PRKAA1 protein |
CTD |
PMID:26443543 |
|
NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
|
|
G |
Prkcb |
protein kinase C, beta |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of and results in increased activity of PRKCB protein] |
CTD |
PMID:21355597 |
|
NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
|
|
G |
Psme3 |
proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki) |
decreases expression |
ISO |
pterostilbene results in decreased expression of PSME3 protein |
CTD |
PMID:24936659 |
|
NCBI chr11:101,206,090...101,214,363
Ensembl chr11:101,207,039...101,214,363
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO EXP |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein] pterostilbene inhibits the reaction [Azoxymethane results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein] |
CTD |
PMID:18551458 PMID:19549798 PMID:20681671 PMID:21355597 PMID:22842666 PMID:23731018 More...
|
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]] |
CTD |
PMID:34474091 |
|
NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
pterostilbene results in decreased expression of RB1 protein |
CTD |
PMID:20398797 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO EXP |
[pterostilbene co-treated with Quercetin] affects the localization of RELA protein; [pterostilbene co-treated with Quercetin] results in decreased activity of [NFKB1 protein binds to RELA protein]; RELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein] pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of RELA protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of RELA protein] |
CTD |
PMID:18551458 PMID:18852136 PMID:21355597 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Ripk1 |
receptor (TNFRSF)-interacting serine-threonine kinase 1 |
multiple interactions |
ISO |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein]]; pterostilbene inhibits the reaction [Ethanol promotes the reaction [RIPK1 protein binds to RIPK3 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein] |
CTD |
PMID:34474091 |
|
NCBI chr13:34,181,072...34,219,153
Ensembl chr13:34,186,346...34,221,130
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
multiple interactions |
ISO |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]]; pterostilbene inhibits the reaction [Ethanol promotes the reaction [RIPK1 protein binds to RIPK3 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]] |
CTD |
PMID:34474091 |
|
NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
|
|
G |
Rps12 |
ribosomal protein S12 |
decreases expression |
ISO |
pterostilbene results in decreased expression of RPS12 protein |
CTD |
PMID:24936659 |
|
NCBI chr10:23,661,042...23,664,297
Ensembl chr10:23,661,081...23,663,173
|
|
G |
Sars1 |
seryl-tRNA synthetase 1 |
increases expression |
ISO |
pterostilbene results in increased expression of SARS1 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr 3:108,332,180...108,352,575
Ensembl chr 3:108,332,181...108,352,525
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
EXP ISO |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of SESN2 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN1A protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN2A protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of H2AX protein modified form]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of SESN2 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 4:132,220,115...132,237,767
Ensembl chr 4:132,219,343...132,237,812
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
[resveratrol co-treated with pterostilbene] results in decreased expression of SIRT1 mRNA; [resveratrol co-treated with pterostilbene] results in decreased expression of SIRT1 protein |
CTD |
PMID:26459286 |
|
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
|
|
G |
Sirt2 |
sirtuin 2 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of SIRT2 protein]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NFATC4 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr 7:28,466,192...28,488,086
Ensembl chr 7:28,466,160...28,488,086
|
|
G |
Slc22a12 |
solute carrier family 22 (organic anion/cation transporter), member 12 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [potassium oxonate results in increased expression of SLC22A12 protein] |
CTD |
PMID:22865646 |
|
NCBI chr19:6,585,884...6,593,100
Ensembl chr19:6,585,875...6,593,062
|
|
G |
Snai1 |
snail family zinc finger 1 |
decreases expression |
ISO |
pterostilbene results in decreased expression of SNAI1 protein |
CTD |
PMID:23921149 |
|
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions increases expression |
ISO |
[pterostilbene co-treated with kaempferol] results in increased expression of SOD1 protein; [pterostilbene co-treated with Quercetin] results in increased expression of SOD1 protein; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of SOD1 mRNA] pterostilbene results in increased expression of SOD1 protein |
CTD |
PMID:25111660 PMID:33930484 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
multiple interactions increases expression increases activity |
ISO EXP |
[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein; HDAC5 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; MAPK7 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; pterostilbene inhibits the reaction [HDAC5 protein binds to SOD2 promoter]; pterostilbene promotes the reaction [KLF2 protein binds to SOD2 promoter]; pterostilbene results in increased expression of and results in increased activity of SOD2 protein; SP1 protein affects the reaction [[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein] pterostilbene results in increased expression of SOD2 protein ESR2 gene mutant form inhibits the reaction [pterostilbene results in increased expression of SOD2 protein]; fulvestrant inhibits the reaction [pterostilbene results in increased expression of SOD2 protein] pterostilbene results in increased activity of SOD2 protein |
CTD |
PMID:18852136 PMID:22450950 PMID:22572619 PMID:24361291 PMID:26443543 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Sp1 |
trans-acting transcription factor 1 |
multiple interactions |
ISO |
SP1 protein affects the reaction [[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein] |
CTD |
PMID:18852136 |
|
NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO EXP |
bafilomycin A1 inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; Cycloheximide promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]] |
CTD |
PMID:34405320 |
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases expression decreases phosphorylation decreases activity |
ISO EXP |
pterostilbene results in decreased expression of STAT3 protein modified form pterostilbene results in decreased phosphorylation of STAT3 protein pterostilbene results in decreased activity of STAT3 protein |
CTD |
PMID:22450950 PMID:23313376 PMID:26138072 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Stk11 |
serine/threonine kinase 11 |
increases phosphorylation |
ISO |
pterostilbene results in increased phosphorylation of STK11 protein |
CTD |
PMID:26443543 |
|
NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516
|
|
G |
Terf1 |
telomeric repeat binding factor 1 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Ethanol results in increased expression of TERF1 protein] |
CTD |
PMID:34405320 |
|
NCBI chr 1:15,875,634...15,914,283
Ensembl chr 1:15,875,870...15,914,276
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases expression multiple interactions |
ISO |
pterostilbene results in decreased expression of TERT mRNA; pterostilbene results in decreased expression of TERT protein pterostilbene inhibits the reaction [Ethanol results in decreased expression of TERT mRNA]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of TERT protein]; Resveratrol promotes the reaction [pterostilbene results in decreased expression of TERT mRNA]; Resveratrol promotes the reaction [pterostilbene results in decreased expression of TERT protein] |
CTD |
PMID:26459286 PMID:34405320 |
|
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]] pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]] |
CTD |
PMID:19549798 PMID:22698256 PMID:23731018 PMID:34405320 PMID:34474091 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
decreases expression |
ISO |
pterostilbene results in decreased expression of TPT1 protein |
CTD |
PMID:24936659 |
|
NCBI chr14:76,082,771...76,085,743
Ensembl chr14:76,082,533...76,085,965
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression |
ISO |
pterostilbene results in increased expression of TP53 mRNA |
CTD |
PMID:20152895 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
increases glucuronidation decreases activity multiple interactions |
ISO |
UGT1A1 protein results in increased glucuronidation of pterostilbene pterostilbene results in decreased activity of UGT1A1 protein pterostilbene inhibits the reaction [[UGT1A1 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] |
CTD |
PMID:23965644 PMID:31812603 |
|
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
|
|
G |
Ugt1a10 |
UDP glycosyltransferase 1 family, polypeptide A10 |
affects glucuronidation |
ISO |
UGT1A10 protein affects the glucuronidation of pterostilbene |
CTD |
PMID:23965644 |
|
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
multiple interactions decreases activity increases glucuronidation |
ISO |
pterostilbene inhibits the reaction [[UGT1A3 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] pterostilbene results in decreased activity of UGT1A3 protein UGT1A3 protein results in increased glucuronidation of pterostilbene |
CTD |
PMID:23965644 PMID:31812603 |
|
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
|
|
G |
Ugt1a6b |
UDP glucuronosyltransferase 1 family, polypeptide A6B |
decreases activity multiple interactions |
ISO |
pterostilbene results in decreased activity of UGT1A6 protein pterostilbene inhibits the reaction [[UGT1A6 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] |
CTD |
PMID:31812603 |
|
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
affects glucuronidation decreases activity multiple interactions |
ISO |
UGT1A9 protein affects the glucuronidation of pterostilbene pterostilbene results in decreased activity of UGT1A9 protein pterostilbene inhibits the reaction [[UGT1A9 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] |
CTD |
PMID:23965644 PMID:31812603 |
|
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
|
|
G |
Ugt2b34 |
UDP glucuronosyltransferase 2 family, polypeptide B34 |
decreases activity multiple interactions |
ISO |
pterostilbene results in decreased activity of UGT2B7 protein pterostilbene inhibits the reaction [[UGT2B7 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] |
CTD |
PMID:31812603 |
|
NCBI chr 5:87,037,613...87,054,805
Ensembl chr 5:87,037,626...87,054,796
|
|
G |
Umod |
uromodulin |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [potassium oxonate results in increased expression of UMOD protein] |
CTD |
PMID:22865646 |
|
NCBI chr 7:119,061,931...119,078,485
Ensembl chr 7:119,061,934...119,078,505
|
|
G |
Zfp488 |
zinc finger protein 488 |
decreases expression |
ISO |
pterostilbene results in decreased expression of ZNF488 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr14:33,689,023...33,700,986
Ensembl chr14:33,689,027...33,700,721
|
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
increases activity |
ISO |
rhapontigenin analog results in increased activity of ESR1 protein |
CTD |
PMID:17935960 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Esr2 |
estrogen receptor 2 (beta) |
multiple interactions increases activity |
ISO |
Fulvestrant inhibits the reaction [rhapontigenin analog results in increased activity of ESR2 protein] |
CTD |
PMID:17692514 PMID:17935960 |
|
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
|
|
G |
Trf |
transferrin |
multiple interactions |
ISO |
rhapontigenin analog inhibits the reaction [Lipopolysaccharides results in increased activity of TF protein] |
CTD |
PMID:16507316 |
|
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
|
|
|
G |
Abcb10 |
ATP-binding cassette, sub-family B member 10 |
decreases expression |
ISO |
pinosylvin results in decreased expression of ABCB10 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:124,679,198...124,709,877
Ensembl chr 8:124,679,198...124,709,861
|
|
G |
Abce1 |
ATP-binding cassette, sub-family E member 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of ABCE1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:80,410,071...80,438,369
Ensembl chr 8:80,410,091...80,438,369
|
|
G |
Arhgap29 |
Rho GTPase activating protein 29 |
decreases expression |
ISO |
pinosylvin results in decreased expression of ARHGAP29 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 3:121,746,752...121,810,326
Ensembl chr 3:121,746,190...121,810,402
|
|
G |
Art1 |
ADP-ribosyltransferase 1 |
increases expression |
ISO |
pinosylvin results in increased expression of ART1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:101,750,913...101,771,410
Ensembl chr 7:101,750,950...101,763,140
|
|
G |
Bag2 |
BCL2-associated athanogene 2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of BAG2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:33,784,565...33,796,831
Ensembl chr 1:33,784,565...33,796,876
|
|
G |
Bcap29 |
B cell receptor associated protein 29 |
decreases expression |
ISO |
pinosylvin results in decreased expression of BCAP29 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:31,645,353...31,684,657
Ensembl chr12:31,640,966...31,684,657
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
multiple interactions |
ISO |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BMP4 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126
|
|
G |
Cbx3 |
chromobox 3 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CBX3 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:51,447,596...51,460,684
Ensembl chr 6:51,447,340...51,460,684
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CCNA2 protein |
CTD |
PMID:23333577 |
|
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA pinosylvin results in decreased expression of CCND1 protein |
CTD |
PMID:23333577 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CCNE1 protein |
CTD |
PMID:23333577 |
|
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
|
|
G |
Cdca2 |
cell division cycle associated 2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CDCA2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr14:67,910,629...67,953,290
Ensembl chr14:67,913,780...67,953,290
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CDK2 protein |
CTD |
PMID:23333577 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdk2ap1 |
cyclin dependent kinase 2 associated protein 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CDK2AP1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:124,483,502...124,492,691
Ensembl chr 5:124,483,480...124,501,145
|
|
G |
Cdk4 |
cyclin dependent kinase 4 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CDK4 protein |
CTD |
PMID:23333577 |
|
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
|
|
G |
Cdk8 |
cyclin dependent kinase 8 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CDK8 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:146,167,432...146,239,684
Ensembl chr 5:146,168,040...146,239,684
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
increases expression |
ISO |
pinosylvin results in increased expression of CDKN1A mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
pinosylvin results in decreased expression of CENPF mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:189,372,803...189,420,302
Ensembl chr 1:189,372,803...189,420,283
|
|
G |
Cep290 |
centrosomal protein 290 |
increases expression |
ISO |
pinosylvin results in increased expression of CEP290 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:100,323,410...100,409,527
Ensembl chr10:100,323,420...100,410,702
|
|
G |
Chaf1b |
chromatin assembly factor 1, subunit B |
decreases expression |
ISO |
pinosylvin results in decreased expression of CHAF1B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr16:93,680,801...93,703,003
Ensembl chr16:93,680,789...93,703,003
|
|
G |
Chd1 |
chromodomain helicase DNA binding protein 1 |
increases expression |
ISO |
pinosylvin results in increased expression of CHD1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:15,925,229...15,992,874
Ensembl chr17:15,925,229...15,992,872
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of CKS2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr13:51,799,268...51,804,698
Ensembl chr13:51,799,268...51,804,696
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
decreases expression |
ISO |
pinosylvin results in decreased expression of COX5A mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 9:57,423,012...57,439,710
Ensembl chr 9:57,428,557...57,439,709
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
decreases expression |
ISO |
pinosylvin results in decreased expression of COX7C mRNA |
CTD |
PMID:23333577 |
|
NCBI chr13:86,192,917...86,194,914
Ensembl chr13:86,192,935...86,195,023
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
ISO |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BMP4 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of ID2 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MMP7 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MYC mRNA; pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein |
CTD |
PMID:23333577 |
|
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
|
|
G |
Dchs2 |
dachsous cadherin related 2 |
increases expression |
ISO |
pinosylvin results in increased expression of DCHS2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 3:83,032,589...83,270,336
Ensembl chr 3:83,035,255...83,264,516
|
|
G |
Dhx15 |
DEAH-box helicase 15 |
decreases expression |
ISO |
pinosylvin results in decreased expression of DHX15 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:52,307,545...52,347,888
Ensembl chr 5:52,307,545...52,347,856
|
|
G |
Dsg1a |
desmoglein 1 alpha |
decreases expression |
ISO |
pinosylvin results in decreased expression of DSG1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr18:20,443,982...20,476,407
Ensembl chr18:20,443,868...20,476,407
|
|
G |
Eno1 |
enolase 1, alpha non-neuron |
decreases expression |
ISO |
pinosylvin results in decreased expression of ENO1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336 Ensembl chr18:150,321,178...150,333,336
|
|
G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
increases expression |
ISO |
pinosylvin results in increased expression of ERCC1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
|
|
G |
Etfb |
electron transferring flavoprotein, beta polypeptide |
increases expression |
ISO |
pinosylvin results in increased expression of ETFB mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:43,093,496...43,107,224
Ensembl chr 7:43,093,507...43,107,224
|
|
G |
Fbxo8 |
F-box protein 8 |
increases expression |
ISO |
pinosylvin results in increased expression of FBXO8 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:57,004,189...57,046,974
Ensembl chr 8:57,004,125...57,046,974
|
|
G |
Fdps |
farnesyl diphosphate synthetase |
decreases expression |
ISO |
pinosylvin results in decreased expression of FDPS mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266
|
|
G |
Fh1 |
fumarate hydratase 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of FH mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
|
|
G |
Fth1 |
ferritin heavy polypeptide 1 |
increases expression |
ISO |
pinosylvin results in increased expression of FTH1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
increases expression |
ISO |
pinosylvin results in increased expression of GADD45A mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
pinosylvin results in increased expression of GDF15 mRNA; pinosylvin results in increased expression of GDF15 protein |
CTD |
PMID:23333577 |
|
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
|
|
G |
Gnai1 |
G protein subunit alpha i1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of GNAI1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:18,470,133...18,565,411
Ensembl chr 5:18,470,133...18,565,353
|
|
G |
Gtf2h5 |
general transcription factor IIH, polypeptide 5 |
decreases expression |
ISO |
pinosylvin results in decreased expression of GTF2H5 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:6,130,103...6,135,763
Ensembl chr17:6,130,061...6,136,792
|
|
G |
H3f3b |
H3.3 histone B |
decreases expression |
ISO |
pinosylvin results in decreased expression of H3-3B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:115,912,787...115,921,313
Ensembl chr11:115,912,738...115,918,788
|
|
G |
Hal |
histidine ammonia lyase |
increases expression |
ISO |
pinosylvin results in increased expression of HAL mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:93,324,630...93,352,623
Ensembl chr10:93,324,630...93,355,166
|
|
G |
Hmox2 |
heme oxygenase 2 |
increases expression |
ISO |
pinosylvin results in increased expression of HMOX2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr16:4,544,225...4,584,606
Ensembl chr16:4,544,225...4,584,606
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of HSP90AB1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
multiple interactions decreases expression |
ISO |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of ID2 mRNA pinosylvin results in decreased expression of ID2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase |
decreases expression |
ISO |
pinosylvin results in decreased expression of IDI1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr13:8,935,642...8,942,432
Ensembl chr13:8,935,537...8,942,487
|
|
G |
Il1rap |
interleukin 1 receptor accessory protein |
decreases expression |
ISO |
pinosylvin results in decreased expression of IL1RAP mRNA |
CTD |
PMID:23333577 |
|
NCBI chr16:26,400,259...26,548,878
Ensembl chr16:26,400,454...26,548,867
|
|
G |
Irf2bp1 |
interferon regulatory factor 2 binding protein 1 |
increases expression |
ISO |
pinosylvin results in increased expression of IRF2BP1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:18,737,983...18,740,688
Ensembl chr 7:18,737,969...18,740,702
|
|
G |
Jag1 |
jagged 1 |
increases expression |
ISO |
pinosylvin results in increased expression of JAG1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
|
|
G |
Kbtbd6 |
kelch repeat and BTB (POZ) domain containing 6 |
decreases expression |
ISO |
pinosylvin results in decreased expression of KBTBD6 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr14:79,689,275...79,692,256
Ensembl chr14:79,689,275...79,692,258
|
|
G |
Lrrc25 |
leucine rich repeat containing 25 |
increases expression |
ISO |
pinosylvin results in increased expression of LRRC25 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:71,068,810...71,073,501
Ensembl chr 8:71,068,805...71,074,133
|
|
G |
Lsm6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
ISO |
pinosylvin results in decreased expression of LSM6 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:79,531,497...79,547,781
Ensembl chr 8:79,531,494...79,547,769
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
decreases expression |
ISO |
pinosylvin results in decreased expression of MCM5 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:75,836,096...75,855,067
Ensembl chr 8:75,836,197...75,855,067
|
|
G |
Metap2 |
methionine aminopeptidase 2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of METAP2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:93,694,351...93,732,952
Ensembl chr10:93,694,351...93,732,955
|
|
G |
Mex3d |
mex3 RNA binding family member D |
decreases expression |
ISO |
pinosylvin results in decreased expression of MEX3D mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:80,216,189...80,223,485
Ensembl chr10:80,216,189...80,223,493
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
multiple interactions |
ISO |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MMP7 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,587
|
|
G |
Mrpl14 |
mitochondrial ribosomal protein L14 |
decreases expression |
ISO |
pinosylvin results in decreased expression of MRPL14 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:45,991,689...46,009,421
Ensembl chr17:45,997,248...46,009,421
|
|
G |
Mrpl41 |
mitochondrial ribosomal protein L41 |
decreases expression |
ISO |
pinosylvin results in decreased expression of MRPL41 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:24,862,482...24,865,110
Ensembl chr 2:24,864,129...24,865,110
|
|
G |
Mt4 |
metallothionein 4 |
increases expression |
ISO |
pinosylvin results in increased expression of MT4 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:94,863,832...94,865,659
Ensembl chr 8:94,863,825...94,865,659
|
|
G |
Myc |
myelocytomatosis oncogene |
multiple interactions decreases expression |
ISO |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MYC mRNA pinosylvin results in decreased expression of MYC protein |
CTD |
PMID:23333577 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Nup35 |
nucleoporin 35 |
decreases expression |
ISO |
pinosylvin results in decreased expression of NUP35 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:80,469,156...80,490,415
Ensembl chr 2:80,447,580...80,489,250
|
|
G |
Oaz1 |
ornithine decarboxylase antizyme 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of OAZ1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:80,662,490...80,665,124
Ensembl chr10:80,662,516...80,665,124
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
pinosylvin results in decreased expression of PCNA mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Polr2j |
polymerase (RNA) II (DNA directed) polypeptide J |
increases expression |
ISO |
pinosylvin results in increased expression of POLR2J mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:136,145,545...136,151,801
Ensembl chr 5:136,145,485...136,151,801
|
|
G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
decreases expression |
ISO |
pinosylvin results in decreased expression of PPAT mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:77,061,096...77,099,425
Ensembl chr 5:77,061,096...77,099,425
|
|
G |
Ptges2 |
prostaglandin E synthase 2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of PTGES2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:32,285,902...32,292,752
Ensembl chr 2:32,285,908...32,295,784
|
|
G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of PTK2 protein modified form |
CTD |
PMID:23333577 |
|
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
|
|
G |
Pxmp4 |
peroxisomal membrane protein 4 |
increases expression |
ISO |
pinosylvin results in increased expression of PXMP4 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:154,427,678...154,445,592
Ensembl chr 2:154,427,678...154,445,628
|
|
G |
Rad23b |
RAD23 homolog B, nucleotide excision repair protein |
decreases expression |
ISO |
pinosylvin results in decreased expression of RAD23B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:55,350,042...55,392,237
Ensembl chr 4:55,350,043...55,392,237
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of RB1 protein |
CTD |
PMID:23333577 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Rbbp8 |
retinoblastoma binding protein 8, endonuclease |
decreases expression |
ISO |
pinosylvin results in decreased expression of RBBP8 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr18:11,766,333...11,876,264
Ensembl chr18:11,766,333...11,878,278
|
|
G |
Rbx1 |
ring-box 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of RBX1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr15:81,350,517...81,360,570
Ensembl chr15:81,350,497...81,360,570
|
|
G |
Rrm2 |
ribonucleotide reductase M2 |
decreases expression |
ISO |
pinosylvin results in decreased expression of RRM2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145
|
|
G |
Sec22b |
SEC22 homolog B, vesicle trafficking protein |
increases expression |
ISO |
pinosylvin results in increased expression of SEC22B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 3:97,808,543...97,829,634
Ensembl chr 3:97,808,506...97,830,592
|
|
G |
Serbp1 |
serpine1 mRNA binding protein 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of SERBP1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:67,243,963...67,266,286
Ensembl chr 6:67,215,160...67,274,720
|
|
G |
Sgta |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
increases expression |
ISO |
pinosylvin results in increased expression of SGTA mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:80,879,905...80,896,105
Ensembl chr10:80,879,909...80,896,015
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
increases expression |
ISO |
pinosylvin results in increased expression of SLC38A2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr15:96,585,267...96,597,609
Ensembl chr15:96,585,273...96,597,611
|
|
G |
Snrpb2 |
U2 small nuclear ribonucleoprotein B |
decreases expression |
ISO |
pinosylvin results in decreased expression of SNRPB2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:142,904,989...142,913,972
Ensembl chr 2:142,904,959...142,914,773
|
|
G |
Snrpg |
small nuclear ribonucleoprotein polypeptide G |
decreases expression |
ISO |
pinosylvin results in decreased expression of SNRPG mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:86,348,522...86,355,884
Ensembl chr 6:86,348,286...86,356,310
|
|
G |
Src |
Rous sarcoma oncogene |
decreases expression |
ISO |
pinosylvin results in decreased expression of SRC protein modified form |
CTD |
PMID:23333577 |
|
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
|
|
G |
Srsf10 |
serine and arginine-rich splicing factor 10 |
decreases expression |
ISO |
pinosylvin results in decreased expression of SRSF10 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:135,582,454...135,597,219
Ensembl chr 4:135,583,058...135,597,219
|
|
G |
Srsf11 |
serine and arginine-rich splicing factor 11 |
decreases expression |
ISO |
pinosylvin results in decreased expression of SRSF11 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 3:157,716,552...157,742,304
Ensembl chr 3:157,716,110...157,742,276
|
|
G |
Srsf3 |
serine and arginine-rich splicing factor 3 |
decreases expression |
ISO |
pinosylvin results in decreased expression of SFRS3 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:29,251,634...29,262,346
Ensembl chr17:29,251,602...29,262,347
|
|
G |
Ssbp1 |
single-stranded DNA binding protein 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of SSBP1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:40,448,302...40,458,757
Ensembl chr 6:40,448,286...40,461,634
|
|
G |
Stx6 |
syntaxin 6 |
increases expression |
ISO |
pinosylvin results in increased expression of STX6 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:155,034,374...155,083,405
Ensembl chr 1:155,034,461...155,084,002
|
|
G |
Tbc1d25 |
TBC1 domain family, member 25 |
increases expression |
ISO |
pinosylvin results in increased expression of TBC1D25 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr X:8,020,709...8,042,420
Ensembl chr X:8,020,711...8,042,420
|
|
G |
Timm13 |
translocase of inner mitochondrial membrane 13 |
decreases expression |
ISO |
pinosylvin results in decreased expression of TIMM13 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:80,735,284...80,736,803
Ensembl chr10:80,735,284...80,736,803
|
|
G |
Tmed2 |
transmembrane p24 trafficking protein 2 |
increases expression |
ISO |
pinosylvin results in increased expression of TMED2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:124,678,835...124,688,566
Ensembl chr 5:124,678,758...124,688,569
|
|
G |
Tmprss3 |
transmembrane protease, serine 3 |
decreases expression |
ISO |
pinosylvin results in decreased expression of TMPRSS3 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:31,398,237...31,419,478
Ensembl chr17:31,398,239...31,417,951
|
|
G |
Tnrc6c |
trinucleotide repeat containing 6C |
decreases expression |
ISO |
pinosylvin results in decreased expression of TNRC6C mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:117,544,529...117,654,265
Ensembl chr11:117,545,115...117,654,265
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression |
ISO |
pinosylvin results in increased expression of TP53 protein |
CTD |
PMID:23333577 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Tsc22d1 |
TSC22 domain family, member 1 |
increases expression |
ISO |
pinosylvin results in increased expression of TSC22D1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr14:76,652,401...76,745,205
Ensembl chr14:76,652,401...76,745,205
|
|
G |
Tuba1b |
tubulin, alpha 1B |
decreases expression |
ISO |
pinosylvin results in decreased expression of TUBA1B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr15:98,829,310...98,832,271
Ensembl chr15:98,829,306...98,832,446
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
decreases expression |
ISO |
pinosylvin results in decreased expression of TUBB mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:36,144,812...36,149,193
Ensembl chr17:36,144,813...36,149,198
|
|
G |
Ube2d1 |
ubiquitin-conjugating enzyme E2D 1 |
decreases expression |
ISO |
pinosylvin results in decreased expression of UBE2D1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:71,090,810...71,121,048
Ensembl chr10:71,090,810...71,121,092
|
|
G |
Ubxn2a |
UBX domain protein 2A |
decreases expression |
ISO |
pinosylvin results in decreased expression of UBXN2A mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:4,926,814...4,957,749
Ensembl chr12:4,929,032...4,957,705
|
|
G |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
increases expression |
ISO |
pinosylvin results in increased expression of UCHL1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:66,833,464...66,844,577
Ensembl chr 5:66,833,434...66,844,577
|
|
G |
Usp22 |
ubiquitin specific peptidase 22 |
decreases expression |
ISO |
pinosylvin results in decreased expression of USP22 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:61,042,607...61,065,885
Ensembl chr11:61,042,611...61,065,881
|
|
G |
Usp7 |
ubiquitin specific peptidase 7 |
increases expression |
ISO |
pinosylvin results in increased expression of USP7 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr16:8,506,586...8,574,931
Ensembl chr16:8,507,459...8,610,172
|
|
G |
Zbtb44 |
zinc finger and BTB domain containing 44 |
decreases expression |
ISO |
pinosylvin results in decreased expression of ZBTB44 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 9:30,941,016...30,987,181
Ensembl chr 9:30,941,940...30,987,181
|
|
G |
Zfp207 |
zinc finger protein 207 |
decreases expression |
ISO |
pinosylvin results in decreased expression of ZNF207 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:80,274,105...80,299,387
Ensembl chr11:80,274,105...80,296,559
|
|
G |
Zfp330 |
zinc finger protein 330 |
decreases expression |
ISO |
pinosylvin results in decreased expression of ZNF330 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:83,490,247...83,500,774
Ensembl chr 8:83,490,236...83,500,789
|
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:32662907 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of HMOX1 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of HMOX1 protein] |
CTD |
PMID:32662907 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of IL10 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of IL10 protein] |
CTD |
PMID:32662907 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Ins1 |
insulin I |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:32662907 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Keap1 |
kelch-like ECH-associated protein 1 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in increased expression of KEAP1 mRNA]; rhapontin inhibits the reaction [Streptozocin results in increased expression of KEAP1 protein] |
CTD |
PMID:32662907 |
|
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in increased expression of MMP2 mRNA] |
CTD |
PMID:32662907 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] |
CTD |
PMID:32662907 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of NQO1 mRNA] |
CTD |
PMID:32662907 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of TIMP1 mRNA] |
CTD |
PMID:32662907 |
|
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA] |
CTD |
PMID:32662907 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Ar |
androgen receptor |
affects binding |
ISO |
4,4'-dihydroxystilbene binds to AR protein |
CTD |
PMID:14565775 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
ISO |
4,4'-dihydroxystilbene results in increased expression of CCNA2 mRNA |
CTD |
PMID:19496085 |
|
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
|
|
G |
Ctsd |
cathepsin D |
increases expression |
ISO |
4,4'-dihydroxystilbene results in increased expression of CTSD mRNA |
CTD |
PMID:19496085 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
decreases activity decreases expression |
ISO |
4,4'-dihydroxystilbene results in decreased activity of ECE1 protein 4,4'-dihydroxystilbene results in decreased expression of ECE1 mRNA |
CTD |
PMID:21554123 |
|
NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540
|
|
G |
Edn1 |
endothelin 1 |
decreases secretion decreases expression |
ISO |
4,4'-dihydroxystilbene results in decreased secretion of EDN1 protein 4,4'-dihydroxystilbene results in decreased expression of EDN1 mRNA |
CTD |
PMID:21554123 |
|
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
multiple interactions |
ISO |
4,4'-dihydroxystilbene analog binds to and results in increased activity of ESR1 protein; fulvestrant inhibits the reaction [4,4'-dihydroxystilbene analog binds to and results in increased activity of ESR1 protein] |
CTD |
PMID:19496085 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
increases expression |
ISO |
4,4'-dihydroxystilbene results in increased expression of FOS mRNA |
CTD |
PMID:19496085 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Pgr |
progesterone receptor |
increases expression |
ISO |
4,4'-dihydroxystilbene results in increased expression of PGR mRNA |
CTD |
PMID:19496085 |
|
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
4,4'-dihydroxystilbene binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
4,4'-dihydroxystilbene results in increased expression of TFF1 mRNA |
CTD |
PMID:19496085 |
|
NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251
|
|